Correction to: Decision Analysis: Omadacycline Relative to Moxifoxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difcile Infection

Clin Drug Investig. 2021 Jun;41(6):593. doi: 10.1007/s40261-021-01039-0.

Authors

Thomas P Lodise¹, Rohit Mistry², Kate Young³, Kenneth LaPensee⁴

Affiliations

¹ Albany College of Pharmacy and the Health Sciences, 106 New Scotland Avenue, Albany, NY, 12189, USA. [email protected].
² PAREXEL Access Consulting, London, UK.
³ PAREXEL Access Consulting, Waltham, MA, USA.
⁴ Paratek Pharmaceuticals, Inc, King of Prussia, PA, USA.

No abstract available

Publication types

Published Erratum